IL10 and metabolic dysfunction-associated steatotic liver disease: The increased concentrations of IL-10 observed in our research are in concordance with recent observations on immune dysregulation in NAFLD that includes modulation of inflammatory and adipocytokine levels and altered Th17/Treg balance [35].